TRANSITION TO GMP STANDARDS AS A FACTOR OF EXPORT POTENTIAL GROWTH OF RUSSIAN PHARMACEUTICAL COMPANIES
This article is devoted to the analysis of the practice of introducing GMP standards in the Russian Federation. The author outlines five main directions for the transition of Russian pharmaceutical companies to new international quality standards. In the article, the issues of quality, safety and efficacy of drugs are considered as factors of increasing the export potential of pharmaceutical manufacturers.